IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CANCARINI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.279
EU - Europa 7.674
AS - Asia 6.137
SA - Sud America 1.233
Continente sconosciuto - Info sul continente non disponibili 297
AF - Africa 142
OC - Oceania 16
AN - Antartide 1
Totale 28.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.072
CN - Cina 2.215
SG - Singapore 2.017
IT - Italia 1.922
PL - Polonia 1.551
UA - Ucraina 1.465
BR - Brasile 1.023
DE - Germania 772
HK - Hong Kong 683
FR - Francia 418
FI - Finlandia 414
VN - Vietnam 362
GB - Regno Unito 335
RU - Federazione Russa 260
TR - Turchia 223
IE - Irlanda 222
IN - India 181
BD - Bangladesh 159
CA - Canada 96
AR - Argentina 67
NL - Olanda 63
MX - Messico 59
SE - Svezia 59
BE - Belgio 51
ID - Indonesia 48
EC - Ecuador 43
IQ - Iraq 43
ZA - Sudafrica 35
NG - Nigeria 34
JP - Giappone 29
VE - Venezuela 26
PK - Pakistan 25
AT - Austria 24
ES - Italia 23
CZ - Repubblica Ceca 22
CO - Colombia 21
IR - Iran 20
PY - Paraguay 19
UZ - Uzbekistan 19
MA - Marocco 17
SA - Arabia Saudita 16
AU - Australia 15
EG - Egitto 15
LT - Lituania 14
CL - Cile 13
EU - Europa 13
JO - Giordania 13
JM - Giamaica 11
PE - Perù 10
RO - Romania 10
TN - Tunisia 10
HN - Honduras 9
KZ - Kazakistan 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
OM - Oman 8
KE - Kenya 7
DZ - Algeria 6
HR - Croazia 6
LV - Lettonia 6
NP - Nepal 6
UY - Uruguay 6
BG - Bulgaria 5
CH - Svizzera 5
CR - Costa Rica 5
ET - Etiopia 5
IL - Israele 5
KR - Corea 5
LB - Libano 5
PH - Filippine 5
BO - Bolivia 4
GT - Guatemala 4
PA - Panama 4
PS - Palestinian Territory 4
PT - Portogallo 4
BB - Barbados 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
KW - Kuwait 3
MY - Malesia 3
NO - Norvegia 3
PR - Porto Rico 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BN - Brunei Darussalam 2
GR - Grecia 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
SC - Seychelles 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AO - Angola 1
Totale 28.474
Salva come PNG Salva come JPEG
Città #
Warsaw 1.548
Fairfield 1.359
Woodbridge 1.152
Singapore 1.054
Jacksonville 1.048
Ashburn 1.043
Houston 790
Hong Kong 679
Ann Arbor 618
Chandler 593
Cambridge 591
Seattle 505
Wilmington 463
The Dalles 440
Beijing 426
Princeton 418
Nanjing 370
San Jose 362
New York 294
Dallas 231
Dublin 219
Milan 218
Council Bluffs 214
Helsinki 212
Istanbul 187
Lauterbourg 184
Columbus 172
Los Angeles 168
Nanchang 137
Ho Chi Minh City 131
Munich 125
Rome 119
Dearborn 114
Des Moines 107
Buffalo 106
Brescia 102
Hebei 82
Moscow 80
São Paulo 80
Shenyang 79
Jiaxing 77
Changsha 75
San Diego 73
Tianjin 72
Hanoi 65
Santa Clara 55
Jinan 53
Shanghai 53
Verona 49
Redondo Beach 48
Brussels 47
Chicago 45
Dong Ket 44
London 41
Kunming 40
San Francisco 39
Naples 38
Orem 38
Boardman 36
Toronto 36
Abuja 34
Chennai 34
Hangzhou 32
Florence 31
Turin 31
Atlanta 30
Rio de Janeiro 30
Brooklyn 28
Lanzhou 28
Belo Horizonte 26
Frankfurt am Main 26
Mexico City 26
Phoenix 26
Tokyo 26
Ningbo 24
Stockholm 24
Lancaster 23
San Mateo 23
Turku 23
Denver 22
Nuremberg 22
Bologna 21
Jakarta 21
Palermo 21
Zhengzhou 21
Augusta 20
Brno 20
Bergamo 19
Curitiba 19
Falls Church 19
Guangzhou 19
Genoa 18
Monmouth Junction 18
Montreal 17
Quito 17
Amsterdam 16
Baghdad 16
Bari 16
Catania 16
Leawood 16
Totale 18.763
Salva come PNG Salva come JPEG
Nome #
Mancata ripopolazione dei B linfociti periferici dopo un singolo ciclo di Rituximab in pazienti con vasculite ANCA associata (AAV) all'esordio mai esposti in precedenza a farmaci immunosoppressivi 1.248
Vasculiti ANCA associate (AAV) con presenza di indicatore sierico di attivazione della via alterna del complemento: valutazione degli outcomes. 502
Incremental peritoneal dialysis: a 10 year single-centre experience 326
PRIMA E DOPO IL TRAPIANTO DI RENE: EMODIALISI VS. DIALISI PERITONEALE. 306
SOVRAPPESO POST-DIALITICO E INFIAMMAZIONE CRONICA: UNA ASSOCIAZIONE PERICOLOSA. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI. 281
Low-protein diets for chronic kidney disease patients: The Italian experience 265
SCLEROSI PERITONEALE INCAPSULANTE IN DIALISI PERITONEALE: UNA “BELVA” IN GABBIA? 264
EFFETTO DELLA TERAPIA CON INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA SUI LIVELLI SIERICI DI POTASSIO NEI PAZIENTI EMODIALIZZATI. UNO STUDIO OSSERVAZIONALE 261
CORREZIONE DELL’IPOVITAMINOSI D [25(OH)D3] NEL PAZIENTE DIALIZZATO. EFFETTI SUL METABOLISMO CALCIO-FOSFORICO 261
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 254
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. 254
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. 252
END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION 248
L’ENTITÀ’ DEL SOVRAPPESO POST-DIALITICO E’ ASSOCIATO CON LA MORTALITA’ TOTALE E CARDIOVASCOLARE NEI PAZIENTI EMODIALIZZATI. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI 236
Varianti della malattia da anticorpi anti-GBM (mAbGBM): malattia renale da anticorpi anti-GBM in assenza di anticorpi circolanti 235
RUOLO DELLA COMPONENTE CONVETTIVA SULLE VARIAZIONI SIERICHE DI BETA 2 MICROGLOBULINA (?B2M), PROTEINA C REATTIVA (?HSCRP), E FABBISOGNO DI EPO (?EPO) IN PAZIENTI EMODIALIZZATI TRATTATI CON HDF ON-LINE POST DILUZIONALE. 232
PERITONITE DA MYCOBACTERIUM ABSCESSUS IN CAPD: CASE REPORT. 230
IL RUOLO DEL GRADIENTE DIALITICO DEL SODIO SULL’AUMENTO DEI VALORI DI PRESSIONE ARTERIOSA DURANTE LA DIALISI. UNO STUDIO OSSERVAZIONALE 212
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 202
Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. 197
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 196
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 192
Pregnancy outcomes after kidney graft in Italy: Are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 190
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 189
Vascular access in older patients: an Italian survey. 188
The MEST score provides earlier risk prediction in lgA nephropathy 185
Magnitude of End-Dialysis Overweight is Associated with All-Cause and Cardiovascular Mortality: A 3-Year Prospective Study. 181
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: Results of the FARO-2 cohort 181
A more tubulocentric view of diabetic kidney disease 181
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 180
Differing dialysis treatment strategies and outcome. 177
A six year comparison of patient and technique survivals in CAPD and HD 175
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 174
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 173
Nutritional treatment of advanced CKD: twenty consensus statements 173
A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. 171
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 171
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 171
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. 167
Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. 167
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. 167
Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration 166
A competing risks model with a time dependent variable: the effects of hypertension onset in the comorbidities history in type 2 diabetes 159
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 159
Monoclonal Lambda Free Liht Chains:biochemical behavoiur and pathogenetic classification 159
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 159
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 157
TRANSUDATIVE PLEURAL EFFUSION DUE TO PLEUROPERITONEAL COMMUNICATION IN PERITONEAL DIALYSIS PATIENTS WITH POLYCISTIC KIDNEY DISEASE 156
PERITONITE IN DP: CONFRONTO TRA METODICHE 155
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort 153
Which vascular access for chronic hemodialysis in uremic elderly patients? 148
Assessment of calcemic status in dialyzed uraemic patients. 147
Clinical policies on the management of chronic kidney disease patients in Italy. 145
How to manage elderly patients with chronic renal failure: conservative management versus dialysis 145
MALNUTRITION INFLAMMATION SCORE AND RISK OF HOSPITALISATION AND MORTALITY IN PERITONEAL DIALYSIS PATIENTS. 145
Adeguatezza del trattamento dialitico: aspetti pratici. 144
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 143
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 143
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 143
Experience with cyclosporine. 143
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study 142
Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study 142
Myocardial ultrasound tissue characterization in patients with chronic renal failure 141
Carotid Artery Structural Alterations In Patients With Apolipoprotein A-i Amyloidosis (leu75pro) 141
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 141
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. 141
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 140
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 140
Porphyria and pseudo-porphyria in hemodialyzed patients. 139
Dialysis initiation: what's the rush? 139
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 139
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 138
Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral((R)) plus Rapamune((R)): four-yr results of a randomized monocenter study. 138
PD or not PD? That is the question. 136
Steroid-free immunosuppression regime reduces both long-term cardiovascular morbidity and patient mortality in renal transplant recipients 136
Role of dialysis sodium gradient on intradialytic hypertension: an observational study. 136
PERITONITE IN DP: DIABETICI vs. NON-DIABETICI 136
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. 133
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. 133
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience 133
Diethylene Glycol Poisoning From Transcutaneous Absorption 132
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 132
Transplantation outcome in patients PD and HD 132
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. 132
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 131
'Y' connector system for prevention of peritonitis in CAPD: a controlled study. 131
Management of hypertension in chronic renal failure. 131
Strategy for preventing peritoneal dialysis failure. 130
Porphyria cutanea tarda in a haemodialysed patient. 128
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. 127
Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation. 127
Renal transplantation and peritoneal dialysis 126
Retroperitoneal fibrosis at the onset of ANCA associated vasculitis: The risk of a delay in the diagnosis of vasculitis 126
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 126
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 125
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. 124
Ciclosporina (Cs) nei trapianti di rene: è utile il monitoraggio dei through-levels (BTL)? 124
Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience 124
Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region 124
Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications. 124
Totale 18.204
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.578 0 298 45 106 42 88 98 146 80 210 139 326
2022/20231.820 239 22 28 185 167 476 24 202 268 24 86 99
2023/20241.448 92 35 68 109 61 226 69 85 358 34 44 267
2024/20253.634 50 78 44 363 486 291 368 150 431 264 670 439
2025/20266.481 563 864 678 952 528 455 896 238 407 510 267 123
2026/2027690 425 265 0 0 0 0 0 0 0 0 0 0
Totale 28.779